Neda A. Sharifi



Neda A. Sharifi, Ph.D. is an associate and business lawyer with Foley & Lardner LLP. Her practice is focused on corporate and securities laws matters, including mergers and acquisitions and securities law compliance counseling. She also handles a wide variety of commercial contracts, including technology related agreements. Dr. Sharifi is a member of the firm’s Transactional & Securities and Finance & Financial Institutions Practices.

Dr. Sharifi has advised inventors on protection and management of intellectual property rights. She has prosecuted numerous domestic and foreign patent applications. Her experience has also included providing scientific advice to international and national corporations.

Prior to joining Foley, Dr. Sharifi served as a registered patent agent to a large corporate law firm.

Publications and Presentations

Dr. Sharifi has authored several published peer-reviewed scientific articles as well as a book chapter. Her publications include:

  • “VC Funds Face Risk Appointing Representatives To Board,” Corporate Board Member, April 12, 2018
  • “Delaware Court Invalidates Supermajority Bylaw to Remove Directors Without Cause,” Westlaw Journal: Expert Analysis, March 20, 2017
  • “CEOs Provide Common Sense Corporate Governance Principles,” Bloomberg BNA: Corporate Law & Accountability Report, October 18, 2016
  • “Bylaw Wars: Boards Awaken,” The Corporate Board, March/April 2016
  • “Delaware Curbs Frivolous Merger Suits with More Critical Review of Disclosure-Only Pacts,” Westlaw Journal: Delaware Corporate, October 12, 2015
  • “Delaware Court Delays C&J Energy Merger for Flawed Sale Process,” Westlaw Journal: Corporate Officers & Directors Liability, December 15, 2014

Dr. Sharifi is also a regular speaker, having presented at several national and international conferences regarding research findings in gene regulation.


Dr. Sharifi has been listed among the “Who’s Who in the World,” “Who’s Who in America,” and “Who’s Who in Science and Engineering.”


Dr. Sharifi earned her juris doctor from Florida Coastal School of Law (J.D., magna cum laude), and completed her doctoral degree in human genetics and molecular biology at the Johns Hopkins School of Medicine (Ph.D.).

Dr. Sharifi earned her bachelor’s degree in physiology and neurobiology from the University of Maryland.


Dr. Sharifi is admitted to practice before the United States Patent and Trademark Office. She is also admitted to practice law in Florida.


Dr. Sharifi is fluent in Farsi.



VC Funds Face Risk Appointing Representatives To Board
12 April 2018
Corporate Board Member
Delaware Court Invalidates Supermajority Bylaw to Remove Directors Without Cause
20 March 2017
Westlaw Journal Corporate Officers & Directors Liability
CEOs Provide Common Sense Corporate Governance Principles
18 October 2016
Bloomberg BNA’s Corporate Law & Accountability Report
Delaware Court Delays C&J Energy Merger for Flawed Sale Process
15 December 2014
Westlaw Journal
Bylaw Wars: Boards Awaken
03 March 2016
The Corporate Board
Foley Advises Lindblad Expeditions in Merger
13 March 2015
National Business Institute: Business Contracts A to Z
19 September 2017
Jacksonville, FL